Pasithea Therapeutics KTTAW Stock
Pasithea Therapeutics Price Chart
Pasithea Therapeutics KTTAW Financial and Trading Overview
| Pasithea Therapeutics stock price | 0.0072 USD |
| Previous Close | 0.0072 USD |
| Open | 0.01 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0046 - 0.0072 USD |
| 52 Week Range | 0.0046 - 0.0072 USD |
| Volume | 3.2K USD |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (5Y Monthly) | 0.224 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
KTTAW Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.0032757053 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Pasithea Therapeutics Stock Price History
| Beta (5Y Monthly) | 0.224 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | 27.18% |
| 52 Week High | 0.0072 USD |
| 52 Week Low | 0.0046 USD |
| 50-Day Moving Average | N/A |
| 200-Day Moving Average | N/A |
KTTAW Share Statistics
| Avg. Volume (3 month) | N/A |
| Avg. Daily Volume (10-Days) | N/A |
| Shares Outstanding | N/A |
| Float | 18.68M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -31.49% |
| Return on Equity (ttm) | -58.22% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -17232384 USD |
| Net Income Avi to Common (ttm) | -19733928 USD |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 50.4M USD |
| Total Cash Per Share (mrq) | 1.51 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 35.402 |
| Book Value Per Share (mrq) | 2.198 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -16942952 USD |
| Levered Free Cash Flow (ttm) | -11838196 USD |
Profile of Pasithea Therapeutics
| Country | United States |
| State | FL |
| City | Miami Beach |
| Address | 1111 Lincoln Road |
| ZIP | 33139 |
| Phone | 786 977 3380 |
| Website | https://www.pasithea.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 5 |
Pasithea Therapeutics Corp., a clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers. Its lead product candidate is PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor to treat a range of RASopathies, including neurofibromatosis type 1 (NF1); MAPK pathway-driven tumors, such as BRAFv600 and BRAF fusion tumor; and ETS2 driven diseases, including inflammatory bowel disease (IBD), primary sclerosing cholangitis, and ankylosing spondylitis. The company's lead development candidate is PAS-003, to treat amyotrophic lateral sclerosis. It also intends to develop PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Q&A For Pasithea Therapeutics Stock
What is a current KTTAW stock price?
Pasithea Therapeutics KTTAW stock price today per share is 0.0072 USD.
How to purchase Pasithea Therapeutics stock?
You can buy KTTAW shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pasithea Therapeutics?
The stock symbol or ticker of Pasithea Therapeutics is KTTAW.
How many shares does Pasithea Therapeutics have in circulation?
The max supply of Pasithea Therapeutics shares is 0.
What is Pasithea Therapeutics Price to Earnings Ratio (PE Ratio)?
Pasithea Therapeutics PE Ratio is now.
What was Pasithea Therapeutics earnings per share over the trailing 12 months (TTM)?
Pasithea Therapeutics EPS is 0 USD over the trailing 12 months.